NE LB230

Establishes the Kratom Consumer Protection Act prohibiting sale of kratom products to persons under 21, banning products attractive to children, and requiring manufacturing facilities to meet FDA food facility registration and 21 C.F.R. Part 111 standards

Requires kratom product labels to include warnings about use by minors/pregnant persons, habit-forming potential, FDA disclaimer, processor information, serving size directions, and alkaloid content listings including mitragynine and 7-hydroxymitragynine

Creates a Department of Revenue product registration program for kratom products by January 1, 2026, with civil penalties ranging from $1,000 for first violations up to $20,000 for third/subsequent violations, plus potential 3-year sales bans for processors

Prohibits businesses from selling nitrous oxide products or flavored nitrous oxide products to consumers, with exceptions for denatured products, manufacturing/automotive use, medical prescriptions, and food propellants; violations constitute Class II misdemeanor (first offense) or Class I misdemeanor (subsequent) plus $2,500 civil penalty

Adds tianeptine to Schedule II controlled substances and butorphanol to Schedule IV, removes lorcaserin from Schedule IV, and makes technical amendments to controlled substance schedules under the Uniform Controlled Substances Act